# Treatment of Coronary In-Stent Restenosis

> **NCT01735825** · NA · COMPLETED · sponsor: **University Hospital Ostrava** · enrollment: 199 (actual)

## Conditions studied

- Restenosis

## Interventions

- **DEVICE:** paclitaxel-coated balloon catheter with Iopromide coating
- **DEVICE:** drug eluting stent with everolimus
- **DEVICE:** seal-wing paclitaxel-eluting balloon catheter

## Key facts

- **NCT ID:** NCT01735825
- **Lead sponsor:** University Hospital Ostrava
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2015-07
- **Final completion:** 2018-06
- **Target enrollment:** 199 (ACTUAL)
- **Last updated:** 2022-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01735825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01735825, "Treatment of Coronary In-Stent Restenosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01735825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*